Alliance for Better Bone Health

18.09.2007 – 08:24
Actonel Halves Risk of Fracture in Osteoporotic Women With History of Hip Fracture
Honolulu, Hawaii (ots/PRNewswire) - New data show that Actonel(R) 5mg (risedronate sodium tablets) reduces the risk of clinical fractures by half versus placebo over three years in postmenopausal women with osteoporosis who have suffered a previous hip fracture(1)- a group of patients at high risk of a subsequent fracture. These results are from a retrospective ...
mehr
17.11.2006 – 12:48
Study of Over 33,000 Women Comparing Two Most Prescribed Osteoporosis Treatments Shows Significant Difference in Hip Fracture Reduction
Paris, November 17 (ots/PRNewswire) - - Actonel Almost Halves the Risk of Breaking a Hip When Compared to Alendronate in the First Year of Treatment - For Non-US Journalists Only Data published today from a retrospective study of over 33,000 postmenopausal women showed that among patients newly ...
mehr